W. Neidhart et al., DISCOVERY OF RO-48-5695 - A POTENT MIXED ENDOTHELIN RECEPTOR ANTAGONIST OPTIMIZED FROM BOSENTAN, Bioorganic & medicinal chemistry letters, 7(17), 1997, pp. 2223-2228
Implementation of a pyridylcarbamoyl group and an isopropylpyridylsulf
onamide substituent as key components in the scaffold of Bosentan resu
lted in the identification of the potent orally active endothelin rece
ptor antagonist Ro 48-5695. It shows affinities for ETA and ETB recept
ors in the low nanomolar range and high functional antagonistic potenc
y in vitro. (C) 1997 Elsevier Science Ltd.